0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rituximab Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-4X15263
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Rituximab Injection Market Research Report 2023
BUY CHAPTERS

Global Rituximab Injection Market Research Report 2025

Code: QYRE-Auto-4X15263
Report
May 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rituximab Injection Market Size

The global market for Rituximab Injection was valued at US$ 2293 million in the year 2024 and is projected to reach a revised size of US$ 8172 million by 2031, growing at a CAGR of 20.2% during the forecast period.

Rituximab Injection Market

Rituximab Injection Market

Rituximab injection sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer.
North American market for Rituximab Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Rituximab Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Rituximab Injection include Pfizer, Amgen, Roche, Celltrion, Innovent Biologics, Intas Pharmaceuticals, Shanghai Henlius Biotech, Fosun-Pharmaceutical, Lexicare Pharma, Healthiza Lifescience, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rituximab Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rituximab Injection.
The Rituximab Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rituximab Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rituximab Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rituximab Injection Market Report

Report Metric Details
Report Name Rituximab Injection Market
Accounted market size in year US$ 2293 million
Forecasted market size in 2031 US$ 8172 million
CAGR 20.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 100 ml
  • 500 ml
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Amgen, Roche, Celltrion, Innovent Biologics, Intas Pharmaceuticals, Shanghai Henlius Biotech, Fosun-Pharmaceutical, Lexicare Pharma, Healthiza Lifescience, Kavya Pharma, Cadila Pharmaceuticals, Dr Reddy’s Laboratories, Hetero Group, Probiomed, TRPharma, Zenotech Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rituximab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Rituximab Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Rituximab Injection Market growing?

Ans: The Rituximab Injection Market witnessing a CAGR of 20.2% during the forecast period 2025-2031.

What is the Rituximab Injection Market size in 2031?

Ans: The Rituximab Injection Market size in 2031 will be US$ 8172 million.

Who are the main players in the Rituximab Injection Market report?

Ans: The main players in the Rituximab Injection Market are Pfizer, Amgen, Roche, Celltrion, Innovent Biologics, Intas Pharmaceuticals, Shanghai Henlius Biotech, Fosun-Pharmaceutical, Lexicare Pharma, Healthiza Lifescience, Kavya Pharma, Cadila Pharmaceuticals, Dr Reddy’s Laboratories, Hetero Group, Probiomed, TRPharma, Zenotech Laboratories

What are the Application segmentation covered in the Rituximab Injection Market report?

Ans: The Applications covered in the Rituximab Injection Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Rituximab Injection Market report?

Ans: The Types covered in the Rituximab Injection Market report are 100 ml, 500 ml

Recommended Reports

Injection Drugs Markets

Immune & Autoimmune Drugs

Oncology & Antibody Therapies

1 Rituximab Injection Market Overview
1.1 Product Definition
1.2 Rituximab Injection by Type
1.2.1 Global Rituximab Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 100 ml
1.2.3 500 ml
1.3 Rituximab Injection by Application
1.3.1 Global Rituximab Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Rituximab Injection Market Size Estimates and Forecasts
1.4.1 Global Rituximab Injection Revenue 2020-2031
1.4.2 Global Rituximab Injection Sales 2020-2031
1.4.3 Global Rituximab Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Rituximab Injection Market Competition by Manufacturers
2.1 Global Rituximab Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Rituximab Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Rituximab Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Rituximab Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rituximab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rituximab Injection, Product Type & Application
2.7 Global Key Manufacturers of Rituximab Injection, Date of Enter into This Industry
2.8 Global Rituximab Injection Market Competitive Situation and Trends
2.8.1 Global Rituximab Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Rituximab Injection Players Market Share by Revenue
2.8.3 Global Rituximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rituximab Injection Market Scenario by Region
3.1 Global Rituximab Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Rituximab Injection Sales by Region: 2020-2031
3.2.1 Global Rituximab Injection Sales by Region: 2020-2025
3.2.2 Global Rituximab Injection Sales by Region: 2026-2031
3.3 Global Rituximab Injection Revenue by Region: 2020-2031
3.3.1 Global Rituximab Injection Revenue by Region: 2020-2025
3.3.2 Global Rituximab Injection Revenue by Region: 2026-2031
3.4 North America Rituximab Injection Market Facts & Figures by Country
3.4.1 North America Rituximab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Rituximab Injection Sales by Country (2020-2031)
3.4.3 North America Rituximab Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rituximab Injection Market Facts & Figures by Country
3.5.1 Europe Rituximab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Rituximab Injection Sales by Country (2020-2031)
3.5.3 Europe Rituximab Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rituximab Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Rituximab Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Rituximab Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Rituximab Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Rituximab Injection Market Facts & Figures by Country
3.7.1 Latin America Rituximab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Rituximab Injection Sales by Country (2020-2031)
3.7.3 Latin America Rituximab Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rituximab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Rituximab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Rituximab Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Rituximab Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rituximab Injection Sales by Type (2020-2031)
4.1.1 Global Rituximab Injection Sales by Type (2020-2025)
4.1.2 Global Rituximab Injection Sales by Type (2026-2031)
4.1.3 Global Rituximab Injection Sales Market Share by Type (2020-2031)
4.2 Global Rituximab Injection Revenue by Type (2020-2031)
4.2.1 Global Rituximab Injection Revenue by Type (2020-2025)
4.2.2 Global Rituximab Injection Revenue by Type (2026-2031)
4.2.3 Global Rituximab Injection Revenue Market Share by Type (2020-2031)
4.3 Global Rituximab Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Rituximab Injection Sales by Application (2020-2031)
5.1.1 Global Rituximab Injection Sales by Application (2020-2025)
5.1.2 Global Rituximab Injection Sales by Application (2026-2031)
5.1.3 Global Rituximab Injection Sales Market Share by Application (2020-2031)
5.2 Global Rituximab Injection Revenue by Application (2020-2031)
5.2.1 Global Rituximab Injection Revenue by Application (2020-2025)
5.2.2 Global Rituximab Injection Revenue by Application (2026-2031)
5.2.3 Global Rituximab Injection Revenue Market Share by Application (2020-2031)
5.3 Global Rituximab Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Rituximab Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Rituximab Injection Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Rituximab Injection Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Celltrion
6.4.1 Celltrion Company Information
6.4.2 Celltrion Description and Business Overview
6.4.3 Celltrion Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Celltrion Rituximab Injection Product Portfolio
6.4.5 Celltrion Recent Developments/Updates
6.5 Innovent Biologics
6.5.1 Innovent Biologics Company Information
6.5.2 Innovent Biologics Description and Business Overview
6.5.3 Innovent Biologics Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Innovent Biologics Rituximab Injection Product Portfolio
6.5.5 Innovent Biologics Recent Developments/Updates
6.6 Intas Pharmaceuticals
6.6.1 Intas Pharmaceuticals Company Information
6.6.2 Intas Pharmaceuticals Description and Business Overview
6.6.3 Intas Pharmaceuticals Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Intas Pharmaceuticals Rituximab Injection Product Portfolio
6.6.5 Intas Pharmaceuticals Recent Developments/Updates
6.7 Shanghai Henlius Biotech
6.7.1 Shanghai Henlius Biotech Company Information
6.7.2 Shanghai Henlius Biotech Description and Business Overview
6.7.3 Shanghai Henlius Biotech Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shanghai Henlius Biotech Rituximab Injection Product Portfolio
6.7.5 Shanghai Henlius Biotech Recent Developments/Updates
6.8 Fosun-Pharmaceutical
6.8.1 Fosun-Pharmaceutical Company Information
6.8.2 Fosun-Pharmaceutical Description and Business Overview
6.8.3 Fosun-Pharmaceutical Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Fosun-Pharmaceutical Rituximab Injection Product Portfolio
6.8.5 Fosun-Pharmaceutical Recent Developments/Updates
6.9 Lexicare Pharma
6.9.1 Lexicare Pharma Company Information
6.9.2 Lexicare Pharma Description and Business Overview
6.9.3 Lexicare Pharma Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Lexicare Pharma Rituximab Injection Product Portfolio
6.9.5 Lexicare Pharma Recent Developments/Updates
6.10 Healthiza Lifescience
6.10.1 Healthiza Lifescience Company Information
6.10.2 Healthiza Lifescience Description and Business Overview
6.10.3 Healthiza Lifescience Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Healthiza Lifescience Rituximab Injection Product Portfolio
6.10.5 Healthiza Lifescience Recent Developments/Updates
6.11 Kavya Pharma
6.11.1 Kavya Pharma Company Information
6.11.2 Kavya Pharma Description and Business Overview
6.11.3 Kavya Pharma Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Kavya Pharma Rituximab Injection Product Portfolio
6.11.5 Kavya Pharma Recent Developments/Updates
6.12 Cadila Pharmaceuticals
6.12.1 Cadila Pharmaceuticals Company Information
6.12.2 Cadila Pharmaceuticals Description and Business Overview
6.12.3 Cadila Pharmaceuticals Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Cadila Pharmaceuticals Rituximab Injection Product Portfolio
6.12.5 Cadila Pharmaceuticals Recent Developments/Updates
6.13 Dr Reddy’s Laboratories
6.13.1 Dr Reddy’s Laboratories Company Information
6.13.2 Dr Reddy’s Laboratories Description and Business Overview
6.13.3 Dr Reddy’s Laboratories Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Dr Reddy’s Laboratories Rituximab Injection Product Portfolio
6.13.5 Dr Reddy’s Laboratories Recent Developments/Updates
6.14 Hetero Group
6.14.1 Hetero Group Company Information
6.14.2 Hetero Group Description and Business Overview
6.14.3 Hetero Group Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hetero Group Rituximab Injection Product Portfolio
6.14.5 Hetero Group Recent Developments/Updates
6.15 Probiomed
6.15.1 Probiomed Company Information
6.15.2 Probiomed Description and Business Overview
6.15.3 Probiomed Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Probiomed Rituximab Injection Product Portfolio
6.15.5 Probiomed Recent Developments/Updates
6.16 TRPharma
6.16.1 TRPharma Company Information
6.16.2 TRPharma Description and Business Overview
6.16.3 TRPharma Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.16.4 TRPharma Rituximab Injection Product Portfolio
6.16.5 TRPharma Recent Developments/Updates
6.17 Zenotech Laboratories
6.17.1 Zenotech Laboratories Company Information
6.17.2 Zenotech Laboratories Description and Business Overview
6.17.3 Zenotech Laboratories Rituximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Zenotech Laboratories Rituximab Injection Product Portfolio
6.17.5 Zenotech Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rituximab Injection Industry Chain Analysis
7.2 Rituximab Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rituximab Injection Production Mode & Process Analysis
7.4 Rituximab Injection Sales and Marketing
7.4.1 Rituximab Injection Sales Channels
7.4.2 Rituximab Injection Distributors
7.5 Rituximab Injection Customer Analysis
8 Rituximab Injection Market Dynamics
8.1 Rituximab Injection Industry Trends
8.2 Rituximab Injection Market Drivers
8.3 Rituximab Injection Market Challenges
8.4 Rituximab Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Rituximab Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Rituximab Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Rituximab Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Rituximab Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Rituximab Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Rituximab Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Rituximab Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Rituximab Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Rituximab Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Rituximab Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Rituximab Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Rituximab Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Rituximab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rituximab Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Rituximab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Rituximab Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Rituximab Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Rituximab Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Rituximab Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Rituximab Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Rituximab Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Rituximab Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Rituximab Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Rituximab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Rituximab Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Rituximab Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Rituximab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Rituximab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Rituximab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Rituximab Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Rituximab Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Rituximab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Rituximab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Rituximab Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Rituximab Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Rituximab Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Rituximab Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Rituximab Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Rituximab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Rituximab Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Rituximab Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Rituximab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Rituximab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Rituximab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Rituximab Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Rituximab Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Rituximab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Rituximab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Rituximab Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Rituximab Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Rituximab Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Rituximab Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Rituximab Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Rituximab Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Rituximab Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Rituximab Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Rituximab Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Rituximab Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Rituximab Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Rituximab Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Rituximab Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Rituximab Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Rituximab Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Rituximab Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Rituximab Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Rituximab Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Rituximab Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Rituximab Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Rituximab Injection Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Amgen Company Information
 Table 76. Amgen Description and Business Overview
 Table 77. Amgen Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Amgen Rituximab Injection Product
 Table 79. Amgen Recent Developments/Updates
 Table 80. Roche Company Information
 Table 81. Roche Description and Business Overview
 Table 82. Roche Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Roche Rituximab Injection Product
 Table 84. Roche Recent Developments/Updates
 Table 85. Celltrion Company Information
 Table 86. Celltrion Description and Business Overview
 Table 87. Celltrion Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Celltrion Rituximab Injection Product
 Table 89. Celltrion Recent Developments/Updates
 Table 90. Innovent Biologics Company Information
 Table 91. Innovent Biologics Description and Business Overview
 Table 92. Innovent Biologics Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Innovent Biologics Rituximab Injection Product
 Table 94. Innovent Biologics Recent Developments/Updates
 Table 95. Intas Pharmaceuticals Company Information
 Table 96. Intas Pharmaceuticals Description and Business Overview
 Table 97. Intas Pharmaceuticals Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Intas Pharmaceuticals Rituximab Injection Product
 Table 99. Intas Pharmaceuticals Recent Developments/Updates
 Table 100. Shanghai Henlius Biotech Company Information
 Table 101. Shanghai Henlius Biotech Description and Business Overview
 Table 102. Shanghai Henlius Biotech Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Shanghai Henlius Biotech Rituximab Injection Product
 Table 104. Shanghai Henlius Biotech Recent Developments/Updates
 Table 105. Fosun-Pharmaceutical Company Information
 Table 106. Fosun-Pharmaceutical Description and Business Overview
 Table 107. Fosun-Pharmaceutical Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Fosun-Pharmaceutical Rituximab Injection Product
 Table 109. Fosun-Pharmaceutical Recent Developments/Updates
 Table 110. Lexicare Pharma Company Information
 Table 111. Lexicare Pharma Description and Business Overview
 Table 112. Lexicare Pharma Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Lexicare Pharma Rituximab Injection Product
 Table 114. Lexicare Pharma Recent Developments/Updates
 Table 115. Healthiza Lifescience Company Information
 Table 116. Healthiza Lifescience Description and Business Overview
 Table 117. Healthiza Lifescience Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Healthiza Lifescience Rituximab Injection Product
 Table 119. Healthiza Lifescience Recent Developments/Updates
 Table 120. Kavya Pharma Company Information
 Table 121. Kavya Pharma Description and Business Overview
 Table 122. Kavya Pharma Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Kavya Pharma Rituximab Injection Product
 Table 124. Kavya Pharma Recent Developments/Updates
 Table 125. Cadila Pharmaceuticals Company Information
 Table 126. Cadila Pharmaceuticals Description and Business Overview
 Table 127. Cadila Pharmaceuticals Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Cadila Pharmaceuticals Rituximab Injection Product
 Table 129. Cadila Pharmaceuticals Recent Developments/Updates
 Table 130. Dr Reddy’s Laboratories Company Information
 Table 131. Dr Reddy’s Laboratories Description and Business Overview
 Table 132. Dr Reddy’s Laboratories Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Dr Reddy’s Laboratories Rituximab Injection Product
 Table 134. Dr Reddy’s Laboratories Recent Developments/Updates
 Table 135. Hetero Group Company Information
 Table 136. Hetero Group Description and Business Overview
 Table 137. Hetero Group Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Hetero Group Rituximab Injection Product
 Table 139. Hetero Group Recent Developments/Updates
 Table 140. Probiomed Company Information
 Table 141. Probiomed Description and Business Overview
 Table 142. Probiomed Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Probiomed Rituximab Injection Product
 Table 144. Probiomed Recent Developments/Updates
 Table 145. TRPharma Company Information
 Table 146. TRPharma Description and Business Overview
 Table 147. TRPharma Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. TRPharma Rituximab Injection Product
 Table 149. TRPharma Recent Developments/Updates
 Table 150. Zenotech Laboratories Company Information
 Table 151. Zenotech Laboratories Description and Business Overview
 Table 152. Zenotech Laboratories Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Zenotech Laboratories Rituximab Injection Product
 Table 154. Zenotech Laboratories Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Rituximab Injection Distributors List
 Table 158. Rituximab Injection Customers List
 Table 159. Rituximab Injection Market Trends
 Table 160. Rituximab Injection Market Drivers
 Table 161. Rituximab Injection Market Challenges
 Table 162. Rituximab Injection Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Rituximab Injection
 Figure 2. Global Rituximab Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rituximab Injection Market Share by Type: 2024 & 2031
 Figure 4. 100 ml Product Picture
 Figure 5. 500 ml Product Picture
 Figure 6. Global Rituximab Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Rituximab Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Others
 Figure 11. Global Rituximab Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Rituximab Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Rituximab Injection Sales (2020-2031) & (K Units)
 Figure 14. Global Rituximab Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. Rituximab Injection Report Years Considered
 Figure 16. Rituximab Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Rituximab Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Rituximab Injection Players: Market Share by Revenue in Rituximab Injection in 2024
 Figure 19. Rituximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Rituximab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Rituximab Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Rituximab Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Rituximab Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Rituximab Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Rituximab Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Rituximab Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Rituximab Injection Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Rituximab Injection Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Rituximab Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Rituximab Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Rituximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Rituximab Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Rituximab Injection by Type (2020-2031)
 Figure 53. Global Rituximab Injection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Rituximab Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Rituximab Injection by Application (2020-2031)
 Figure 56. Global Rituximab Injection Price (US$/Unit) by Application (2020-2031)
 Figure 57. Rituximab Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS